What CNOOC Doubters Missed

If you only glanced at headlines about CNOOC’s record production and fresh discoveries, it would be easy to miss how specific projects fed through to actual returns. Investors who held CNOOC over the past year are up 24.0%, including dividends. If you were weighing a purchase back on 2025-11-04, you had to decide whether expanding reserves and policy support outweighed decarbonization and ESG pressure. Which side of that trade-off looked more convincing then?

If the move has made CNOOC harder to judge, start where the gap is still open and scan 201 high quality undervalued stocks.

The Argument You Would Have Been Weighing On CNOOC

The shares cost HK$20.4 at the start of the period, so anyone looking at CNOOC then had to decide which story about its future cash generation felt more realistic.

The bullish narrative pointed to a Fair Value of HK$22.46, a price implied by assumptions such as revenue growth of 1.8% and a future P/E of 9.4x over three years, supported by aggressive reserve investment and low all-in costs near US$27 per barrel of oil equivalent.

The bearish view argued for a Fair Value of HK$10.59, based on expectations that global decarbonization would pressure demand, with revenue assumed to decline 2.2% a year and profit margins shrinking from 31.8% to 26.3% over the same horizon.

What The Results Changed For CNOOC

CNOOC reported Q3 2026 revenue of CNY112,914m and net income of CNY33,300m, both above Q3 2025 levels, which backed the optimistic case that production growth could still feed into higher profit. Net margin slipped from 30.9% to 29.5%, and ESG and transition worries stayed in view, so the evidence cut both ways rather than settling the argument.

The episode turned on one assumption. Higher volumes and new projects only help you if profitability holds. For any resource producer, it can be useful to track net margin next to output headlines and to test whether each quarter’s income statement keeps up with the production story.

What Today's CNOOC Price Already Assumes

CNOOC now trades at HK$23.78, above where this Narrative’s Fair Value sits. For the Narrative, this suggests recent strength is already reflected in the quote. The focus shifts from past production wins to how future demand, capex and regulation shape the durability of current earnings.

A buyer today effectively assumes CNOOC turns strong cash generation and new projects into steady long term profits. The key question is how the Narrative’s concerns about higher spending and weaker demand could challenge that path without necessarily breaking it.

"The main thing that has to go right is that CNOOC converts its current wave of new projects, rising production and high cash generation into durable earnings and dividends despite higher capital spending and transition risks."

Not everyone reads the same price the same way. → See the lower figure this Narrative lands on, and how it gets there

Before The Next Story Makes Headlines

You may be late to this rally, but that does not have to mean arriving late to every opportunity. Start with companies whose prices leave room for a different view of their future. Here are three trading below our estimates.

• Company 1 - 20% below our estimate - targets infection driven bone procedures where surgeons shift to local antibiotic grafts.
• Company 2 - 40% below our estimate - expands AI powered hiring and local services matching as clients automate more workflows.
• Company 3 - 25% below our estimate - embeds AI assistants into cloud, productivity, coding and business software used daily.

Those are three of them. See the full list of 197 financially solid companies →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com